Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 1.000 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.663 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.634 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.624 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.606 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.603 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.603 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.592 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.592 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.591 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.586 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.573 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.570 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.567 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.563 | |
| 3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.556 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.555 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.549 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.541 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.541 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.530 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.527 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.525 | |
| 4m69 | ANP | Receptor-interacting serine/threonine-protein kinase 3 | 2.7.11.1 | 0.524 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.522 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.517 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.517 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.516 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.515 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.511 | |
| 2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.508 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.507 | |
| 4riy | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.504 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.503 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.501 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.500 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.499 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.499 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.498 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.491 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.491 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.490 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.490 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.489 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.489 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.487 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.486 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.485 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.484 | |
| 2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.483 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.483 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.483 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.483 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.483 | |
| 3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.482 | |
| 4pd6 | URI | Nucleoside permease | / | 0.482 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.481 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.480 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.480 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.478 | |
| 2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
| 4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.476 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.476 | |
| 4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.475 | |
| 1osv | CHC | Bile acid receptor | / | 0.474 | |
| 3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.474 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.474 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.474 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.473 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.471 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.470 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.470 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.470 | |
| 2c3q | GTX | Glutathione S-transferase theta-1 | 2.5.1.18 | 0.468 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.468 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.468 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.467 | |
| 3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.467 | |
| 3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.467 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.467 | |
| 1ot7 | CHC | Bile acid receptor | / | 0.466 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.466 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.466 | |
| 3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 4k2x | FAD | Polyketide oxygenase/hydroxylase | / | 0.466 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 1idb | 0DO | Gag-Pol polyprotein | / | 0.465 | |
| 1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.465 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.465 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.465 | |
| 3ogq | AB1 | Pol polyprotein | / | 0.465 | |
| 2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.464 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.464 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.464 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.464 | |
| 4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.464 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.464 | |
| 4wa9 | AXI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.464 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.464 | |
| 3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
| 3mg3 | ECH | Orange carotenoid-binding protein | / | 0.462 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.462 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.462 | |
| 1mes | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.461 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.461 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.461 | |
| 1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.460 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
| 3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.460 | |
| 4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.460 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
| 2znq | 401 | Peroxisome proliferator-activated receptor delta | / | 0.459 | |
| 3icr | COA | Coenzyme A disulfide reductase | / | 0.459 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.459 | |
| 3tmz | 06X | Cytochrome P450 2B4 | 1.14.14.1 | 0.459 | |
| 3w2c | N15 | Aurora kinase A | 2.7.11.1 | 0.459 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 3l9h | EMQ | Kinesin-like protein KIF11 | / | 0.458 | |
| 3q71 | AR6 | Poly [ADP-ribose] polymerase 14 | 2.4.2.30 | 0.458 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.458 | |
| 4idv | 13V | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.458 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.458 | |
| 1bve | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.457 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.457 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
| 3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.457 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.456 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.456 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.456 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.456 | |
| 4kl9 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
| 2y00 | Y01 | Beta-1 adrenergic receptor | / | 0.455 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.455 | |
| 5e8j | SAH | mRNA cap guanine-N7 methyltransferase | 2.1.1.56 | 0.455 | |
| 1iyz | NDP | Probable quinone oxidoreductase | / | 0.454 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.454 | |
| 2nu9 | COA | Succinate--CoA ligase [ADP-forming] subunit alpha | 6.2.1.5 | 0.454 | |
| 4kz0 | 1UJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.454 | |
| 4xuh | SFI | Peroxisome proliferator-activated receptor gamma | / | 0.454 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.453 | |
| 2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 4z35 | ON9 | Lysophosphatidic acid receptor 1 | / | 0.453 | |
| 1bvg | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.452 | |
| 1y5r | C0R | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.452 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.452 | |
| 3dtc | VIN | Mitogen-activated protein kinase kinase kinase 9 | 2.7.11.25 | 0.452 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 4l2i | FAD | Electron transfer flavoprotein alpha/beta-subunit | / | 0.452 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.452 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.452 | |
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.451 | |
| 2azz | TCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.451 | |
| 2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.451 | |
| 2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.451 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.451 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.451 | |
| 1hpo | UNI | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
| 2gr1 | FAD | Ferredoxin reductase | / | 0.450 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 4a6b | QG8 | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
| 4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.450 | |
| 1dkf | BMS | Retinoic acid receptor alpha | / | 0.449 | |
| 1ot7 | IU5 | Bile acid receptor | / | 0.449 | |
| 1zmd | NAI | Dihydrolipoyl dehydrogenase, mitochondrial | 1.8.1.4 | 0.449 | |
| 3bqr | 4RB | Death-associated protein kinase 3 | / | 0.449 | |
| 3zw3 | ZW3 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
| 4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
| 4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.449 | |
| 2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.448 | |
| 2j9m | PY8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 2r64 | 740 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3sgx | 0FW | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.448 | |
| 4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.448 | |
| 4xld | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.448 | |
| 4xum | IMN | Peroxisome proliferator-activated receptor gamma | / | 0.448 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.448 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.448 | |
| 1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 1kzu | RG1 | Light-harvesting protein B-800/850 alpha chain | / | 0.447 | |
| 1kzu | RG1 | Light-harvesting protein B-800/850 beta chain | / | 0.447 | |
| 2f4b | EHA | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
| 2hnz | PC0 | Gag-Pol polyprotein | 2.7.7.49 | 0.447 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
| 2yaa | ATP | Death-associated protein kinase 2 | / | 0.447 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.447 | |
| 3b70 | NAP | Enoyl reductase LovC | 1 | 0.447 | |
| 3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.447 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.447 | |
| 4mxa | BK7 | Calmodulin-like domain protein kinase isoenzyme gamma, related | / | 0.447 | |
| 1ai9 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
| 1i7i | AZ2 | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
| 1qbs | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.446 | |
| 2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
| 2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.446 | |
| 3axw | TID | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
| 3ol5 | SAW | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
| 4jv8 | 1M1 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.446 | |
| 1iid | NHM | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.445 | |
| 1zem | NAD | Xylitol dehydrogenase | / | 0.445 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.445 | |
| 3iae | D7K | Benzaldehyde lyase | / | 0.445 | |
| 3nx4 | NAP | Putative oxidoreductase | / | 0.445 | |
| 3pgq | GY3 | Acetyl-CoA carboxylase | / | 0.445 | |
| 3sm2 | 478 | Putative gag-pro-pol polyprotein | / | 0.445 | |
| 4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.445 | |
| 4wq4 | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.445 | |
| 1eqh | FLP | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.444 | |
| 1meu | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
| 1ydr | IQP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
| 2j3k | NAP | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.444 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.444 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.444 | |
| 3zdi | UGJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.444 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.444 | |
| 1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
| 1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.443 | |
| 3h0a | D30 | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
| 4cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
| 4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 4j5j | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.443 | |
| 4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.443 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.443 | |
| 1c1d | NAI | Phenylalanine dehydrogenase | / | 0.442 | |
| 1m75 | CAA | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.442 | |
| 2b00 | GCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.442 | |
| 3h86 | AP5 | Adenylate kinase | / | 0.442 | |
| 3n7u | NAD | Formate dehydrogenase, chloroplastic/mitochondrial | / | 0.442 | |
| 3upj | U03 | Gag-Pol polyprotein | / | 0.442 | |
| 3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.442 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.442 | |
| 4nr4 | 2LK | CREB-binding protein | / | 0.442 | |
| 1pn3 | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.441 | |
| 2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 3b6z | CO7 | Enoyl reductase LovC | 1 | 0.441 | |
| 3dga | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.441 | |
| 3kjs | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.441 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3ori | AGS | Serine/threonine protein kinase | / | 0.441 | |
| 3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.441 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.441 | |
| 4an3 | 5Y0 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.441 | |
| 4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.441 | |
| 4l4x | NDP | AmphI | / | 0.441 | |
| 4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 1q1w | FAD | Putidaredoxin reductase | 1.18.1.5 | 0.440 | |
| 1soz | VAL_TYR_GLN_PHE | Serine endoprotease DegS | 3.4.21.107 | 0.440 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 2hwr | DRD | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.440 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.440 | |
| 2w4i | VGA | Glutamate racemase | / | 0.440 | |
| 3ict | COA | Coenzyme A disulfide reductase | / | 0.440 | |
| 4bqr | IBH | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
| 4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.440 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.440 |